James Paul Rickey, See Remarks at ALPINE IMMUNE SCIENCES, INC. (ALPN), sold 104,174 shares at $19.00 ($2.0M) on 2023-12-14, disclosed to the SEC on 2023-12-18.
Scheduled sale ($2.0M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.00 | 11,600 | $220K | 11.1% |
| 2 | $19.09 | 45,387 | $866K | 43.6% |
| 3 | $19.09 | 45,387 | $866K | 43.6% |
| 4 | $19.00 | 1,800 | $34K | 1.7% |
| Total | $19.08 avg | 104,174 | $2.0M | 100% |
| Filing → |
| ALPN | SELL | 2023-12-21 | $584K | — | Filing → |
| ALPN | SELL | 2023-12-06 | $2.3M | — | Filing → |
| ALPN | SELL | 2023-12-01 | $11K | — | Filing → |